YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novartis to buy French drugmaker for $3.9B

Posted online

Swiss pharmaceutical company Novartis AG plans to buy French drugmaker Advanced Accelerator Applications for $3.9 billion.

Advanced Accelerator Application develops molecular nuclear medicine, including Lutathera. It was approved in Europe in September to fight gastroenteropancreatic neuroendocrine tumors.

The deal was approved by Advanced Accelerator Application's board of directors.

Read more from TheStreet.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Open For Business: 9 Lives Tavern

Shortly after getting married, Amos and Shelby Hale became first-time business owners with the July 10 launch of 9 Lives Tavern in downtown Ozark.

Most Read
Update cookies preferences